Lifeboat Foundation

Need a yeast that spits out rose oil? The synthetic biology company Ginkgo Bioworks is on it.

Xconomy National —

Drugs that use molecular scissors to snip out or replace defective genes. Altered mosquitoes meant to sabotage entire disease-carrying populations. Both are potential uses of genome editing, which thanks to the CRISPR-Cas9 system has spread throughout the world’s biology labs and is now on the doorstep of the outside world. But with its first applications could also come unintended consequences for human health and the environment. The U.S. Defense Advanced Research Projects Agency—a famed military R&D group—wants to finance safety measures for the new gene-editing age.

The idea for the funding program, called Safe Genes, is to get out ahead of problems that could bring the field to a screeching halt. “We should couple innovation with biosecurity,” DARPA program manager Renee Wegrzyn, said Tuesday at the SynBioBeta conference in South San Francisco. “We need new safety measures that don’t slow us down. You have brakes in your car so that you can go fast but can stop when you need to.”

Continue reading “With New Program, DARPA To Encourage Safety ‘Brakes’ For Gene Editing” »

In Brief.

• New research concludes that human lifespan has already reached its peak of 125 years.
• The research does not take into account synthetic biology and advancements in biotech that could extend lifespans further.

Scientists at the Albert Einstein College of Medicine assert that they have discovered the maximum lifespan of human beings, and it’s a range we may no longer be able to exceed. Dr. Jan Vijg, professor of ophthalmology and visual sciences at Einstein, lead the research, which was published online today in the journal Nature.

The only thing we know for sure is that everything will change.

What would happen if gene editing fell into the wrong hands?

How we can use CRISPR/Cas9 to treat the processes of aging.

Oliver Medvedik, Cofounder of the Life Extension Advocacy Foundation and the Lifespan.io Crowdfunding platform, discusses the CRISPR/Cas9 gene editing system in depth and highlights how it may be used to help overcome the diseases and disabilities of aging. He also gives an overview of other promising areas in aging research, such as senescent cell-clearing drugs, or “senolytics”, and “augmentive” compounds that may help restore the body to youthful functionality.

Continue reading “CRISPR Cas9: Will it Cure Aging? — Talk” »

Awesome; how about Elephant tusks, etc.

In Brief.

California biotech company Pembient has announced its production of synthetic rhino horns, in the hopes of providing an ethical alternative to purchasing from poachers. Conservationist groups express worries over any unintended impact.

Continue reading “The Age of Biotech: Can Bioengineered Rhino Horns Bring An End to Poaching?” »

Just like checking your bag on a commercial airline, space travel comes with some pretty big weight restrictions. How big? According to estimates, reaching space costs a whopping $10,000 per pound, which means that every ounce saved has a big impact on the bottom line.

That’s where a group of Danish researchers comes in. The team is working on a synthetic biology project called CosmoCrops, which hopes to use bacteria to make it possible to 3D print everything needed for a respectable space mission, using a cutting-edge co-culturing system. And it could even make life better for those of us back on Earth in the process.

“We are trying to make space exploration cheaper, because many inventions we use in our daily life were invented because of space exploration, like Velcro and solar energy,” Joachim Larsen, one of the students working on the project, told Digital Trends. “The way we want to achieve this is to [be] able to produce everything from food to medicine and bioplastic for 3D printers out in space — making the space rocket a lot lighter.”

An annual competition has been launched to assist companies aiming to solve world issues with synthetic biology.

Bio-start offers the winner a combination of £100k cash as well as laboratory space, professional services and a 10 week accelerator programme with mentorship valued at approximately £100k.

Dr Stephen Chambers, CEO of SynbiCITE, one of the companies involved in the founding of the competition said: “This is a first in the UK for synthetic biology and our aim is to help as many companies and entrepreneurs as we can. Once applications have been assessed up to twenty-five businesses will go through our ten-week boot-camp and mentoring programme. Up to ten will go through to the final awards evening where they’ll have a chance to pitch their ideas to an expert panel in front of an audience of investors and industry leaders.”

Continue reading “Synthetic biology competition launched” »